Dermavant Appoints John Darden as New Head of Marketing
Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced the appointment of John Darden as Vice President of Marketing.
- Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced the appointment of John Darden as Vice President of Marketing.
- Darden brings more than 15 years of sales, marketing and market access experience in dermatology and immunology.
- “I am proud to join a company of innovators and disruptors, with deep experience in dermatology and immunology,” said John Darden, Vice President of Marketing at Dermavant.
- “We are thrilled to have John join Dermavant as our new VP of Marketing during a pivotal time in the company’s growth,” said Chris Chapman, Chief Commercial Officer at Dermavant.